Background: Follicular lymphoma (fl) is the most common indolent lymphoma and the 2nd most common non-Hodgkin lymphoma, accounting for 10%-20% of all lymphomas in the Western world. Epidemiologic and geographic trends of fl in Canada have not been investigated. Our study's objective was to analyze incidence and mortality rates and the geographic distribution of fl patients in Canada for 1992-2010. Methods: Demographic and geographic patient data for fl cases were obtained using the Canadian Cancer Registry, the Registre québécois du cancer, and the Canadian Vital Statistics database. Incidence and mortality rates and 95% confidence intervals were calculated per year and per geographic area. Rates were plotted using linear regression models to assess trends over time. Overall data were mapped using Microsoft Excel mapping software (Redmond, WA, U.S.A.) to identify case clusters across Canada. Results: Approximately 22,625 patients were diagnosed with fl during 1992-2010. The age-standardized incidence rate of this malignancy in Canada was 38.3 cases per million individuals per year. Geographic analysis demonstrated that a number of Maritime provinces and Manitoba had the highest incidence rates, and that the provinces of Nova Scotia and Quebec had the highest mortality rates in the nation. Regional data demonstrated clustering of fl within cities or regions with high herbicide use, primary mining, and a strong manufacturing presence. Conclusions: Our study provides a comprehensive overview of the fl burden and its geographic distribution in Canada. Regional clustering of this disease in concentrated industrial zones strongly suggests that multiple environmental factors might play a crucial role in the development of this lymphoma.
Background: Follicular lymphoma (fl) is the most common indolent lymphoma and the 2nd most common non-Hodgkin lymphoma, accounting for 10%-20% of all lymphomas in the Western world. Epidemiologic and geographic trends of fl in Canada have not been investigated. Our study's objective was to analyze incidence and mortality rates and the geographic distribution of flpatients in Canada for 1992-2010. Methods: Demographic and geographic patient data for fl cases were obtained using the Canadian Cancer Registry, the Registre québécois du cancer, and the Canadian Vital Statistics database. Incidence and mortality rates and 95% confidence intervals were calculated per year and per geographic area. Rates were plotted using linear regression models to assess trends over time. Overall data were mapped using Microsoft Excel mapping software (Redmond, WA, U.S.A.) to identify case clusters across Canada. Results: Approximately 22,625 patients were diagnosed with fl during 1992-2010. The age-standardized incidence rate of this malignancy in Canada was 38.3 cases per million individuals per year. Geographic analysis demonstrated that a number of Maritime provinces and Manitoba had the highest incidence rates, and that the provinces of Nova Scotia and Quebec had the highest mortality rates in the nation. Regional data demonstrated clustering of fl within cities or regions with high herbicide use, primary mining, and a strong manufacturing presence. Conclusions: Our study provides a comprehensive overview of the fl burden and its geographic distribution in Canada. Regional clustering of this disease in concentrated industrial zones strongly suggests that multiple environmental factors might play a crucial role in the development of this lymphoma.
Authors: Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet Journal: Blood Date: 2005-09-08 Impact factor: 22.113
Authors: L Amar; M Le; F M Ghazawi; E Rahme; A Segal; E Netchiporouk; G Popradi; L Moreau; O Roshdy; D Sasseville; I V Litvinov Journal: Curr Oncol Date: 2019-02-01 Impact factor: 3.677
Authors: Feras M Ghazawi; Janelle Cyr; Rami Darwich; Michelle Le; Elham Rahme; Linda Moreau; Elena Netchiporouk; Andrei Zubarev; Osama Roshdy; Steven J Glassman; Denis Sasseville; Ivan V Litvinov Journal: J Am Acad Dermatol Date: 2018-08-06 Impact factor: 11.527
Authors: Feras M Ghazawi; Rami Darwich; Michelle Le; Elham Rahme; Andrei Zubarev; Linda Moreau; Julia Valdemarin Burnier; Denis Sasseville; Miguel N Burnier; Ivan V Litvinov Journal: Br J Ophthalmol Date: 2019-02-28 Impact factor: 4.638
Authors: Feras M Ghazawi; Elena Netchiporouk; Elham Rahme; Matthew Tsang; Linda Moreau; Steven Glassman; Nathalie Provost; Martin Gilbert; Sara-Elizabeth Jean; Kevin Pehr; Denis Sasseville; Ivan V Litvinov Journal: Cancer Date: 2017-05-10 Impact factor: 6.860
Authors: Feras M Ghazawi; Elena Netchiporouk; Elham Rahme; Matthew Tsang; Linda Moreau; Steven Glassman; Nathalie Provost; Martin Gilbert; Sara-Elizabeth Jean; Osama Roshdy; Kevin Pehr; Denis Sasseville; Ivan V Litvinov Journal: J Cutan Med Surg Date: 2017-12-14 Impact factor: 2.092
Authors: Feras M Ghazawi; Nebras Alghazawi; Michelle Le; Elena Netchiporouk; Steven J Glassman; Denis Sasseville; Ivan V Litvinov Journal: Front Oncol Date: 2019-04-18 Impact factor: 6.244
Authors: L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov Journal: Curr Oncol Date: 2020-06-01 Impact factor: 3.677
Authors: Rami Abdulbaki; Parastou Tizro; Victor E Nava; Maria Gomes da Silva; João L Ascensão Journal: Curr Oncol Date: 2021-11-18 Impact factor: 3.677
Authors: Santina Conte; Feras M Ghazawi; Michelle Le; Hacene Nedjar; Akram Alakel; François Lagacé; Ilya M Mukovozov; Janelle Cyr; Ahmed Mourad; Wilson H Miller; Joël Claveau; Thomas G Salopek; Elena Netchiporouk; Robert Gniadecki; Denis Sasseville; Elham Rahme; Ivan V Litvinov Journal: Front Med (Lausanne) Date: 2022-03-03
Authors: Aino Rajamäki; Mika Hujo; Reijo Sund; Roosa E I Prusila; Milla E L Kuusisto; Hanne Kuitunen; Esa Jantunen; Santiago Mercadal; Marc Sorigue; Juan-Manuel Sancho; Kaisa Sunela; Outi Kuittinen Journal: Cancer Date: 2022-04-13 Impact factor: 6.921
Authors: Leila Cattelan; Feras M Ghazawi; Michelle Le; François Lagacé; Elham Rahme; Andrei Zubarev; Denis Sasseville; Ivan V Litvinov; Kevin A Waschke; Elena Netchiporouk Journal: Curr Oncol Date: 2021-05-28 Impact factor: 3.677
Authors: Leila Cattelan; Feras M Ghazawi; Michelle Le; François Lagacé; Evgeny Savin; Andrei Zubarev; Jennifer Gantchev; Marcel Tomaszewski; Denis Sasseville; Kevin Waschke; Ivan V Litvinov Journal: Cancer Med Date: 2019-11-12 Impact factor: 4.452